Radotinib(IY-5511) is a novel and selective BCR-ABL1 tyrosine kinase inhibitor with IC50 of 34 nM for wild-type BCR-ABL1 kinase. IC50 value: 34 nM [1] Target: BCR-ABL1 inhibitor Radotinib is a BCR-ABL1 specific 2nd-generation tyrosine kinase inhibitor. A
Molecular Weight:
530.50
Purity:
98.92
CAS Number:
[926037-48-1]
Formula:
C27H21F3N8O
Target:
Bcr-Abl
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
